Candriam SCA’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-266,000
| Closed | -$4.27M | – | 873 |
|
|
2020
Q1 | $4.27M | Hold |
266,000
| – | – | 0.05% | 390 |
|
|
2019
Q4 | $4.37M | Sell |
266,000
-5,000
| -2% | -$82K | 0.05% | 402 |
|
|
2019
Q3 | $3.6M | Hold |
271,000
| – | – | 0.05% | 385 |
|
|
2019
Q2 | $3.8M | Hold |
271,000
| – | – | 0.05% | 393 |
|
|
2019
Q1 | $4.99M | Buy |
271,000
+93,000
| +52% | +$1.71M | 0.06% | 328 |
|
|
2018
Q4 | $4.65M | Buy |
+178,000
| New | +$4.65M | 0.07% | 295 |
|
|
2017
Q3 | – | Sell |
-170,000
| Closed | -$2.77M | – | 748 |
|
|
2017
Q2 | $2.77M | Sell |
170,000
-67,000
| -28% | -$1.09M | 0.05% | 394 |
|
|
2017
Q1 | $3.32M | Hold |
237,000
| – | – | 0.06% | 346 |
|
|
2016
Q4 | $3.78M | Buy |
237,000
+20,000
| +9% | +$319K | 0.09% | 256 |
|
|
2016
Q3 | $3.61M | Buy |
+217,000
| New | +$3.61M | 0.09% | 248 |
|